Tipamedi Oy is a limited company based in Porvoo, registered in 1984. In the financial year ending 31.12.2025, revenue was 1,0 M€ and operating profit 213 t€; equity ratio 98.1 %. Its taxable income in 2024 was 294 t€ and its income taxes 60 t€. It has won 1 public contracts in EU procurement notices.
Financials
| Key figures | 31.12.2025 | 31.12.2024 |
|---|---|---|
| Revenue | 1,0 M€ | 674 t€ |
| Revenue change | 51,3 % | – |
| EBITDA | 199 t€ | 278 t€ |
| EBITDA % | 19,5 % | 41,3 % |
| Operating profit | 213 t€ | 296 t€ |
| Operating margin | 20,9 % | 44,0 % |
| Net profit | 171 t€ | 237 t€ |
| Personnel costs | -53 t€ | -60 t€ |
| Equity ratio | 98,1 % | 96,6 % |
| Quick ratio | 13,27 | 13,90 |
| Current ratio | 29,14 | 13,90 |
| Debt to revenue | 3,1 % | 8,1 % |
| Return on equity | 10,9 % | 15,4 % |
| Balance sheet total | 1,6 M€ | 1,6 M€ |
| Equity | 1,6 M€ | 1,5 M€ |
| Cash and bank | 181 t€ | 191 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 1,0 M€ | 674 t€ |
| Other operating income | 0 € | 43 t€ |
| Raw materials and services | 674 t€ | 237 t€ |
| Personnel expenses | 53 t€ | 60 t€ |
| Depreciations and reductions in value | 13 t€ | 18 t€ |
| Other operating expenses | 67 t€ | 107 t€ |
| Operating profit (loss) | 213 t€ | 296 t€ |
| Financial income and expenses + (-) | -2 427 € | -17 € |
| Profit (loss) before appropriations and taxes | 215 t€ | 296 t€ |
| Income taxes | 44 t€ | 59 t€ |
| Profit (loss) for the financial year | 171 t€ | 237 t€ |
Balance sheet
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Non-current assets | 833 t€ | 878 t€ |
| Stocks | 422 t€ | 0 € |
| Receivables | 172 t€ | 117 t€ |
| Cash in hand and at banks | 181 t€ | 191 t€ |
| Current assets | 774 t€ | 714 t€ |
| Assets | 1,6 M€ | 1,6 M€ |
| Share capital or other similar capital | 2 523 € | 2 523 € |
| Capital and reserves | 1,6 M€ | 1,5 M€ |
| Long-term liabilities | 4 550 € | 3 213 € |
| Short-term liabilities | 27 t€ | 51 t€ |
| Liabilities | 31 t€ | 55 t€ |
All financial statement items (54)
| 31.12.2025 | 31.12.2024 | |
|---|---|---|
| Turnover | 1,0 M€ | 674 t€ |
| Other operating income | 0 € | 43 t€ |
| Raw materials and services | 674 t€ | 237 t€ |
| Personnel expenses | 53 t€ | 60 t€ |
| Depreciations and reductions in value | 13 t€ | 18 t€ |
| Other operating expenses | 67 t€ | 107 t€ |
| Operating profit (loss) | 213 t€ | 296 t€ |
| Financial income and expenses + (-) | -2 427 € | -17 € |
| Profit (loss) before appropriations and taxes | 215 t€ | 296 t€ |
| Income taxes | 44 t€ | 59 t€ |
| Profit (loss) for the financial year | 171 t€ | 237 t€ |
| Non-current assets | 833 t€ | 878 t€ |
| Stocks | 422 t€ | 0 € |
| Receivables | 172 t€ | 117 t€ |
| Cash in hand and at banks | 181 t€ | 191 t€ |
| Current assets | 774 t€ | 714 t€ |
| Assets | 1,6 M€ | 1,6 M€ |
| Share capital or other similar capital | 2 523 € | 2 523 € |
| Capital and reserves | 1,6 M€ | 1,5 M€ |
| Long-term liabilities | 4 550 € | 3 213 € |
| Short-term liabilities | 27 t€ | 51 t€ |
| Liabilities | 31 t€ | 55 t€ |
| Short-term sales receivables | 36 t€ | 50 t€ |
| Other short-term receivables | 15 t€ | 65 t€ |
| Long-term receivables | 99 t€ | 0 € |
| Other receivables (investments) | 0 € | 128 t€ |
| Retained earnings | 1,4 M€ | 1,3 M€ |
| Income from other investments under non-current assets, from other companies | 0 € | 59 t€ |
| Inventory increase (+) or decrease (-) | 41 t€ | 0 € |
| Short-term accrued expenses and deferred income | 12 € | 32 t€ |
| Long-term advances received | 4 550 € | 3 213 € |
| Pension expenses | 18 t€ | 27 t€ |
| Other shares and similar rights of ownership | 793 t€ | 696 t€ |
| Short-term accounts payable | 18 t€ | 20 t€ |
| Other current liabilities | 8 696 € | 0 € |
| Long-term loan receivables | 99 t€ | 0 € |
| Investments | 793 t€ | 824 t€ |
| Other stocks | 422 t€ | 0 € |
| Machinery and equipment | 40 t€ | 54 t€ |
| Other interest and financial income from non-group companies | 3 164 € | 7 465 € |
| Liabilities | 1,6 M€ | 1,6 M€ |
| Shares and holdings | 0 € | 406 t€ |
| Interest expenses and other financial expenses for non-Group companies | 737 € | 68 t€ |
| Purchases during the financial year | 419 t€ | 2 639 € |
| Tangible assets | 40 t€ | 54 t€ |
| Short-term receivables | 72 t€ | 117 t€ |
| Other shares, financial securities | 0 € | 406 t€ |
| Wages and salaries | 23 t€ | 31 t€ |
| Profit (loss) for the period, equity | 171 t€ | 237 t€ |
| Depreciations according to plan | 13 t€ | 18 t€ |
| Services purchased | 213 t€ | 234 t€ |
| Other social security expenses | 11 t€ | 2 654 € |
| Impairment on investments for non-current assets | 0 € | -1 933 € |
| Short-term prepayments and accrued income | 22 t€ | 2 515 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Tipamedi Oy is in the upper half of the industry class manufacture of other medical and dental instruments and supplies (47 companies with taxable income; median 73 t€, 4,1 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.
Public contracts won
- Ortopediset leikkaus-, polikliiniset- ja päivystyspalvelut Etelä-Karjalan hyvinvointialueelleEtelä-Karjalan hyvinvointialue1,5 M€
Follow companies in your area
New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.
Try for free